Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck

PURPOSE: We conducted a Phase II, clinical trial to evaluate the efficacy and safety of a biweekly gemcitabine and paclitaxel (GEMTAX) regimen as second-line treatment in patients with recurrent or metastatic unresectable, squamous cell carcinoma of the head and neck (SCCHN). The primary endpoint wa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Avicenna J Med
Main Authors: Sukari, Ammar, Al-Hajeili, Marwan, Salem, Mohamed, Heilbrun, Lance, Smith, Daryn, Yoo, George, Jacobs, John R, Lin, Ho-Sheng, Kucuk, Omer
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2015
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394570/
https://ncbi.nlm.nih.gov/pubmed/25878965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-0770.154195
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki